EDWARDS LIFESCIENCES EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE; PROSTHESIS, MITRAL VALVE, PERCUTANEOUSLY DELIVERED
|
Back to Search Results |
|
Model Number 9600TFX29A |
Device Problem
Perivalvular Leak (1457)
|
Patient Problem
Hemolysis (1886)
|
Event Date 12/20/2022 |
Event Type
Injury
|
Event Description
|
As reported by implant patient registry, approximately 7 days post tavr procedure with a 29mm sapien 3 valve in the mitral position the patient had a valve in valve procedure due to unknown reasons.Another 29mm sapien 3 valve was implanted.Per medical records review and the fcs, the original procedure was an off label valve in mitral annular calcification.Mild paravalvular leak ws noted immediately post procedure, but as the echocardiographer looked closer, it appeared to be more moderate or severe.The patient experience hemolysis post procedure.The team decided they should implant a second valve more ventricular to help seal the leak.A second 29mm sapien 3 valve was implanted without significant improvement, so they used a vascular plug to seal the residual leak successfully.The pvl has improved, but the patient is still experiencing hemolysis.The team believes that the hemolysis likely had an underlying cause other than the valve.The pvl was due to the area of the mitral annulus inside of the patient's extensive calcium.It is close to 700mm2, which is larger than the 29mm valve they implanted.
|
|
Manufacturer Narrative
|
Thv/tvt registry.This is one of two reports being submitted for this case.Please reference manufacturer report no.2015691-2023-10172.The investigation is ongoing.The device remains implanted.
|
|
Manufacturer Narrative
|
The device was not returned for evaluation.As the device was not returned, visual inspection, functional testing, and dimensional testing were unable to be done.The complaint for deployed valve exhibits paravalvular leak was confirmed based on medical records reviewed.The reported event does not allege a malfunction that could be related to an edwards manufacturing deficiency.A review of ifu/training materials revealed no deficiencies.In this case, thv-in-thv could not resolve the paravalvular leak as the pre-existing implanted valve (thv) had pre-existing paravalvular leak between the implanted valve (1st thv) and native mitral annulus.Per supplement training manual, assessment is recommended prior to mitral valve-in-valve implantation for any significant pre-existing paravalvular leakage.Implanting thv-in-thv at mitral position using the sapien 3 (s3) with the commander delivery system (ds) is not indicated for use.The risk management file captures risks for indicated device use only.Therefore, review of the risk management file is complete, and no further action is required at this time.As such, available information suggests that the procedural factors (pre-existing failure thv with paravalvular leak, off label) may have contributed to the reported complaint event.Complaint histories for all reported events are reviewed against trending control limits monthly, and any excursions above the control limits are assessed and documented as part of this monthly review.There were no ifu/training materials inadequacies or edwards defect identified.Therefore, no corrective or preventative actions or product risk assessment are required.
|
|
Manufacturer Narrative
|
The investigation is ongoing.
|
|
Search Alerts/Recalls
|
|
|